Cargando…
316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection
BACKGROUND: Candidemia is a rare but serious complication of SARS-CoV-2 hospitalization. Combining non-culture and culture-based diagnostics allows earlier identification of candidemia. Given higher reported incidence during COVID-19 surges, we investigated the use of (1-3)-β-D-glucan (BDG) assay at...
Autores principales: | Malik, Yesha, Dupper, Amy, Cusumano, Jaclyn, Patel, Dhruv, Twyman, Kathryn, Altman, Deena, Mazo, Dana, Chasan, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644547/ http://dx.doi.org/10.1093/ofid/ofab466.518 |
Ejemplares similares
-
Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series
por: Cusumano, Jaclyn A, et al.
Publicado: (2020) -
Performance of the beta-glucan test and a dynamic prediction rule to identify patients in the ICU at high risk to develop candidemia
por: Nouer, SA, et al.
Publicado: (2015) -
261. A Single-Center Case Series of Methicillin-Resistant S. aureus Bacteremia with Elevated Minimal Inhibitory Concentrations to Vancomycin
por: Mills, Alexandra, et al.
Publicado: (2020) -
Comparison of β-1-3-D-Glucan and Candida Mannan Biomarker Assays with Serological Tests for the Diagnosis of Candidemia
por: Eades, Christopher P., et al.
Publicado: (2023) -
1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)